CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- 4 Grant or award CEO acquired 1,500,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 600,000 shares (grant or award)
- 4 Planned sale Chief Commercial Officer sold 5,000 shares at an average $32.83 ($164,131)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Commercial Officer sold 6,500 shares at an average $33.08 ($215,014)
- 4 Planned sale Interim PFO and PAO sold 13,564 shares at $33.12 ($449,237)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 1,006 shares at $34.42 ($34,627)
- 4 Planned sale COO & CFO sold 142,292 shares at an average $35.62 ($5,068,974)
- 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 32,145 shares (grant or award)
- 4 Grant or award CHRO acquired 23,570 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 34,285 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 113,570 shares (grant or award)
- 4 Grant or award GENERAL COUNSEL acquired 32,145 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 27,855 shares (grant or award)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 72,645 shares at an average $37.37 ($2,714,767)
- 4 Open-market sale CHRO sold 5,296 shares at $36.83 ($195,046)
- 4 Open-market sale COO & CFO sold 7,809 shares at $36.83 ($287,598)
- 4 Open-market sale GENERAL COUNSEL sold 5,742 shares at $36.83 ($211,472)
Page 5 of 17 · 321 filings